BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.7B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$860M |
| 3 |
Apple
AAPL
|
+$839M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$830M |
| 5 |
GE Aerospace
GE
|
+$800M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$362M |
| 2 |
Tesla
TSLA
|
+$288M |
| 3 |
NVIDIA
NVDA
|
+$265M |
| 4 |
MetLife
MET
|
+$261M |
| 5 |
Meta Platforms (Facebook)
META
|
+$223M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.34% |
| 2 | Consumer Discretionary | 8.14% |
| 3 | Financials | 7.71% |
| 4 | Healthcare | 6.1% |
| 5 | Communication Services | 5.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4651
Nautilus Biotechnolgy
NAUT
$115M
| $12.2K | ﹤0.01% |
+7,250
| New | +$17.3K |
|
|
SILA
4652
DELISTED
Sila Realty Trust
SILA
| $12.2K | ﹤0.01% |
500
-34,029
| -99% | -$857K |
|
4653
Greenwich LifeSciences
GLSI
$244M
| $12.1K | ﹤0.01% |
+1,076
| New | +$14.4K |
|
4654
Acumen Pharmaceuticals
ABOS
$176M
| $12.1K | ﹤0.01% |
+7,017
| New | +$16.9K |
|
4655
Torrid Holdings
CURV
$227M
| $12K | ﹤0.01% |
+2,292
| New | +$9.22K |
|
4656
Traeger
COOK
$172M
| $12K | ﹤0.01% |
+100
| New | +$15.3K |
|
|
ADVM
4657
DELISTED
Adverum Biotechnologies
ADVM
| $11.8K | ﹤0.01% |
2,537
-1,609
| -39% | -$10.8K |
|
|
CMMB
4658
Chemomab Therapeutics
CMMB
$14M
| $11.8K | ﹤0.01% |
+1,625
| New | +$10.3K |
|
4659
Lifeway Foods
LWAY
$382M
| $11.7K | ﹤0.01% |
473
-2,305
| -83% | -$57.6K |
|
|
SUNS
4660
Sunrise Realty Trust
SUNS
$101M
| $11.7K | ﹤0.01% |
831
-493
| -37% | -$7.12K |
|
4661
GrowGeneration
GRWG
$107M
| $11.7K | ﹤0.01% |
+6,920
| New | +$13.2K |
|
4662
Acrivon Therapeutics
ACRV
$74.9M
| $11.7K | ﹤0.01% |
+1,941
| New | +$14.1K |
|
4663
American Well
AMWL
$222M
| $11.6K | ﹤0.01% |
1,595
-8,419
| -84% | -$76.3K |
|
|
WBX
4664
Wallbox
WBX
$74M
| $11.4K | ﹤0.01% |
+1,137
| New | +$18K |
|
|
RGLS
4665
DELISTED
Regulus Therapeutics
RGLS
| $11.3K | ﹤0.01% |
+7,151
| New | +$11K |
|
4666
Tevogen Inc. Common Stock
TVGN
$27.4M
| $11.2K | ﹤0.01% |
218
-61
| -22% | -$3.97K |
|
|
SY
4667
So-Young International
SY
$222M
| $11.2K | ﹤0.01% |
13,500
+600
| +5% | +$543 |
|
|
NOTE
4668
DELISTED
FiscalNote
NOTE
| $10.7K | ﹤0.01% |
+835
| New | +$10.2K |
|
4669
iShares S&P 100 ETF
OEF
$20.5B
| $10.7K | ﹤0.01% |
37
+33
| +825% | +$9.44K |
|
4670
Pembina Pipeline
PBA
$28.4B
| $10.5K | ﹤0.01% |
+284
| New | +$11.6K |
|
4671
Veru
VERU
$45.7M
| $10.4K | ﹤0.01% |
1,592
-3,510
| -69% | -$26K |
|
|
GOCO
4672
DELISTED
GoHealth
GOCO
| $10.3K | ﹤0.01% |
+771
| New | +$8.77K |
|
4673
Offerpad Solutions
OPAD
$22.3M
| $10.3K | ﹤0.01% |
+360
| New | +$12.9K |
|
4674
374Water
SCWO
$45.7M
| $10.1K | ﹤0.01% |
+1,482
| New | +$18.3K |
|
4675
Werewolf Therapeutics
HOWL
$19M
| $10.1K | ﹤0.01% |
+6,832
| New | +$13.9K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2024 Portfolio in Review
As of Q4 2024, BNP Paribas Financial Markets held 5,601 positions worth $178B, up 20% from $149B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BNP Paribas Financial Markets deployed $23.8B of net new capital in Q4 2024, opening 1,444 new positions and adding to 1,732 existing holdings. Its largest new stake was GE Aerospace: 4,486,125 shares worth $748M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street Utilities Select Sector SPDR ETF, an estimated $362M trimmed.
- BNP Paribas Financial Markets's largest Q4 2024 buy was GE Aerospace: 4,486,125 shares worth $748M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $1.7B increase.
- BNP Paribas Financial Markets's biggest Q4 2024 reduction was State Street Utilities Select Sector SPDR ETF, cutting an estimated $362M.
- BNP Paribas Financial Markets fully exited State Street SPDR Portfolio Intermediate Term Corporate Bond ETF in Q4 2024, selling an estimated $34M.
- BNP Paribas Financial Markets's ten largest holdings make up 20% of its $178B portfolio in Q4 2024.
- BNP Paribas Financial Markets opened 1,444 new positions and closed 206 in Q4 2024.
- BNP Paribas Financial Markets's portfolio value rose 20% quarter-over-quarter to $178B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2024, filed 14 Feb 2025.